Disclosures: Kenji Okumura: Nothing to Disclose, Abhay Dhand: Merck: Consultant, Ryosuke Misawa: Nothing to Disclose, Hiroshi Sogawa: Nothing to Disclose, Costica Aloman: Nothing to Disclose, Gregory Veillette: Nothing to Disclose, David Wolf: Abbvie: Speaking and Teaching, Gilead: Speaking and Teaching, Intercept: Speaking and Teaching, Madrigal: Speaking and Teaching, Mallinckrodt: Speaking and Teaching, Seigo Nishida: Nothing to Disclose 943 AN EXPLORATION OF SOCIO-ECONOMIC AND MEDICAL FACTORS INFLUENCING THE LOW CERVICAL CANCER SCREENING UPTAKE AMONG LIVER TRANSPLANT RECIPIENTS - A HIGH VOLUME SINGLE-CENTER RETROSPECTIVE COHORT STUDY Jacquelin Blomker 1 Pavithra Ramakrishnan 1 Katherine Cooke 1 Virginia Hsiao 2 Jessica Makori 2 Claire Collins 2 Mary McConville 2 Jena Benson 2 Katie McLaughlin 2 Rachel Vogel 1 Taylor Bowler 1 Deanna Teoh 1 Elizabeth Aby 1 , 1 University of Minnesota, 2 University of Minnesota Medical School Background: Liver transplant (LT) recipients are at 2 times higher risk of de novo cancer compared to the general population, necessitating appropriate pre-LT and post-LT screening
Angeles Jaime-Sis M
Tom Hermanek, senior, Deans List, College of Business, economics
D3 has inner ring deiodinase activity and degrades T4 to rT3 and T3 to 3,3-T2
